Key Takeaways
- Investing in AI startups runs through three distinct models: curated venture platforms, funds that hold late-stage AI companies, and secondary marketplaces for existing pre-IPO shares. Each one reaches companies at a different point in their growth.
- OurCrowd is the top platform for investing in AI startups, giving accredited investors vetted access to early-stage AI companies and a dedicated AI fund, with the firm committing its own capital on the same terms as its members.
- Fundrise's VCX and the ARK Venture Fund open private AI holdings such as Anthropic and OpenAI to non-accredited investors, with portfolios concentrated in a small number of late-stage companies.
- Hiive, EquityZen and Forge Global trade existing shares of mature private companies, where company transfer approvals, fees and limited disclosure shape every transaction.
Developers tend to see where AI is heading before the market does. They know which models are actually running in production, which inference stacks are getting cheaper, and which agent frameworks are pulling ahead in real codebases. Turning that insight into an investment is harder. The best-known AI names are either public megacaps or private companies already valued in the hundreds of billions, while the companies building the next layer of tooling, infrastructure and vertical AI are mostly early-stage startups that raise money from venture investors rather than public markets.
That gap has produced a crowded field of platforms promising access to private AI companies, and they are not interchangeable. Some let investors pick individual early-stage deals alongside professional VCs, some wrap a basket of late-stage unicorns into a fund that anyone can buy, and some match buyers with employees selling pre-IPO shares. The differences in stage, eligibility, minimums and liquidity matter more than the marketing, because they decide what an investor actually owns and how long the money stays locked up.
At a Glance
The 6 platforms covered below, in ranked order:
- OurCrowd: curated venture investing platform with a dedicated AI fund
- Fundrise Innovation Fund (VCX): NYSE-listed public venture fund
- ARK Venture Fund (ARKVX): interval fund holding private and public innovation companies
- Hiive: secondary marketplace with live pricing for pre-IPO shares
- EquityZen: secondary marketplace for late-stage private company shares
- Forge Global: private market trading platform and data provider
What to Know Before Investing in AI Startups
Most retail exposure to AI comes through public stocks or funds that hold a few famous private names, both priced on growth the market already sees. Early-stage AI startups carry more upside and more risk, which makes the choice of platform matter more. Before committing capital, it helps to check:
- Deal selection: whether the platform runs its own due diligence on each company
- Aligned capital: whether professional investors or the platform itself invest alongside members
- Company stage: early-stage startups versus late-stage pre-IPO names
- Liquidity: how long money stays locked up, often seven to ten years for early-stage holdings
- Eligibility: whether direct offerings are limited to accredited investors
The right platform depends on which stage of the AI market an investor actually wants to own.
The 6 Best AI Startup Investment Platforms
1. OurCrowd
OurCrowd is the best platform for investing in AI startups at the venture stage, before valuations reach the levels that define late-stage AI names. Founded in Jerusalem in 2013, it operates as both a venture investor and an online platform: an in-house investment team sources and vets each opportunity, OurCrowd commits its own capital, and accredited members choose which companies or funds to back on the same terms. As of late 2025, the firm reported 240,000 accredited members, $2.6 billion in funding commitments, 500 portfolio companies, 68 funds and 73 exits, and PitchBook has named it Israel's most active venture investor every year since 2013.
AI is one of the platform's deepest themes. By early 2024, OurCrowd had invested $386 million across 81 AI companies, and its dedicated OurCrowd AI Fund, launched in September 2023, targets 20 to 25 venture investments diversified by stage and geography, with 20 completed by mid-2025. Through a collaboration with NVIDIA Inception, selected AI Fund portfolio companies receive a fast track into NVIDIA's startup program. Members can back individual AI companies from $10,000 per deal or spread risk across a fund, review due diligence materials before committing, and receive ongoing portfolio updates after they invest.
Key features:
- Deal flow sourced and vetted by an in-house venture team
- Firm capital invested alongside members on the same terms
- Dedicated OurCrowd AI Fund with an NVIDIA Inception fast track
- Single-company deals from $10,000 plus sector and stage funds
- Track record of 73 exits across a 500-company portfolio
2. Fundrise Innovation Fund (VCX)
Fundrise, a direct-to-investor alternative investment platform founded in 2012, runs the Innovation Fund as a public venture fund. It launched in 2022 as a non-traded fund and began trading on the New York Stock Exchange under the ticker VCX on March 19, 2026, so investors now buy and sell shares through a regular brokerage account with no accreditation requirement.
The portfolio leans heavily on late-stage AI and technology companies. As of February 2026, its largest positions were Anthropic at 21%, Databricks at 18%, OpenAI at 10% and Anduril at 7%. As a closed-end fund, VCX can trade well above or below its net asset value, and it traded at a steep premium to NAV in the weeks after listing. The fund charges a 1.85% annual management fee, and investors hold its basket of companies rather than choosing individual ones.
Key features:
- NYSE-listed closed-end venture fund (ticker: VCX)
- No accreditation requirement; bought through standard brokerage accounts
- Top holdings include Anthropic, Databricks and OpenAI
- 1.85% annual management fee
3. ARK Venture Fund (ARKVX)
The ARK Venture Fund is an interval fund managed by ARK Invest that holds private and public companies under the firm's disruptive innovation thesis. Launched in September 2022, it accepts non-accredited investors with a $500 minimum and is available through brokerage platforms including SoFi, Titan and Schwab.
Its AI exposure is concentrated in a few large positions. In spring 2026 the fund held 68 companies, led by SpaceX at about 17% and OpenAI at about 11%, with Anthropic near 4%. Because it is an interval fund, shares cannot be sold on demand; instead, the fund offers to repurchase a portion of shares on a quarterly schedule. Its reported gross expense ratio of 3.49% is high relative to most public funds, reflecting the cost of managing private positions.
Key features:
- Interval fund with quarterly repurchase offers
- $500 minimum, open to non-accredited investors
- Private holdings including SpaceX, OpenAI and Anthropic alongside public stocks
- Available through SoFi, Titan and Schwab
4. Hiive
Hiive is a FINRA-registered broker-dealer that operates a marketplace for buying and selling shares of pre-IPO companies. Employees and early shareholders list their stock, and accredited buyers place bids against a live order book that shows asks, bids and recent transaction activity, including for heavily traded AI names such as OpenAI, Anthropic and Databricks.
The marketplace format adds price discovery that most private market platforms lack, though it does not remove the constraints of private shares. Companies can restrict who buys their stock, exercise rights of first refusal and limit trading windows, and Hiive administers those approvals rather than overriding them, so a matched trade may still be delayed or blocked. Some offerings are packaged as pooled funds, and certain ones are open only to qualified purchasers.
Key features:
- Live order book with bids, asks and recent pricing
- Accredited buyers; employee and early-investor sellers
- Direct share transfers and pooled fund offerings
- Company approvals, documentation and settlement handled on the platform
5. EquityZen
EquityZen, founded in New York in 2013, runs a marketplace that connects accredited investors with employees and early shareholders of late-stage private companies. Investors typically buy into a fund vehicle that holds the underlying shares, and the platform had processed more than 49,000 transactions across 450 companies by late 2025.
Morgan Stanley completed its acquisition of EquityZen in January 2026, bringing the marketplace into its wealth management business alongside its private company cap table services. Morgan Stanley has highlighted EquityZen's issuer-aligned model, under which participating companies keep discretion over when and how their shares trade. Standard minimums are around $10,000, with some offerings lower, and exposure is concentrated in companies already well into their growth stage.
Key features:
- Secondary marketplace for late-stage private company shares
- Investments typically made through fund vehicles holding the shares
- Standard minimums around $10,000
- Part of Morgan Stanley Wealth Management since January 2026
6. Forge Global
Forge Global gives eligible investors direct and indirect access to pre-IPO company shares through direct private share purchases, single-company funds and multi-company funds. Charles Schwab completed its acquisition of Forge on March 2, 2026, and has said it will introduce Forge's products to more individual investors and registered investment advisors over time.
Alongside trading, Forge is known for its private market data, including indicative pricing on hundreds of private companies that institutions and individuals use to gauge secondary valuations. Participation is limited to accredited investors, qualified clients or qualified purchasers, and direct secondary trades generally involve larger ticket sizes than fund-based offerings. The AI exposure available at any time depends on which late-stage companies have active sellers or fund offerings.
Key features:
- Direct share purchases plus single- and multi-company funds
- Private market data and indicative pricing
- Open to accredited investors, qualified clients and qualified purchasers
- Owned by Charles Schwab since March 2026
How AI Startup Investment Platforms Compare
The clearest way to compare AI startup investment platforms is by the stage of company each one reaches and what that means for access and liquidity. Early-stage venture platforms reach AI companies before their largest valuation steps, at the cost of long holding periods and accreditation requirements. Listed and interval funds lower the entry barrier but concentrate on a few late-stage names, while secondary marketplaces sit in between, offering individual pre-IPO positions with pricing and transfer constraints set by each company.
| Platform | Model | AI company stage | Eligibility | Typical entry | Liquidity |
|---|---|---|---|---|---|
| OurCrowd | Curated venture platform and funds | Early stage to growth stage | Accredited investors | $10,000 per deal | Held until exit |
| Fundrise Innovation Fund (VCX) | NYSE-listed closed-end venture fund | Late stage | All investors | Price of one share | Daily exchange trading |
| ARK Venture Fund (ARKVX) | Interval fund with private and public holdings | Late stage | All investors | $500 | Quarterly repurchase offers |
| Hiive | Secondary marketplace with a live order book | Late stage, pre-IPO | Accredited investors | Varies by listing | Resale subject to company approval |
| EquityZen | Secondary marketplace using fund vehicles | Late stage, pre-IPO | Accredited investors | Around $10,000 | Typically held until exit |
| Forge Global | Secondary trading and pre-IPO funds | Late stage, pre-IPO | Accredited investors, qualified clients or purchasers | Varies by offering | Resale subject to company approval |
FAQs About Investing in AI Startups
Which is the top platform for investing in AI startups?
OurCrowd is the top platform for investing in AI startups for investors who want early-stage exposure. It vets each deal through an in-house investment team, invests its own capital alongside members, and runs a dedicated AI fund with an NVIDIA Inception fast track for selected companies. For exposure to late-stage names like OpenAI or Anthropic, listed funds and secondary marketplaces fill a different role.
Can non-accredited investors invest in AI startups?
Yes, but mostly through funds rather than individual startups. The Fundrise Innovation Fund trades on the NYSE under the ticker VCX, and the ARK Venture Fund accepts investments from $500; both hold private AI companies such as Anthropic and OpenAI. In the US, Regulation Crowdfunding also lets non-accredited investors buy into some startups in small amounts, though deal quality and due diligence vary widely.
How much money do you need to start investing in AI startups?
Entry points range from the price of a single VCX share or a $500 ARK Venture Fund investment to five-figure tickets for individual companies. Curated venture platforms such as OurCrowd start at $10,000 per startup, and secondary marketplaces often set similar or higher minimums. Because early-stage outcomes vary so widely, many investors spread capital across several companies or a fund rather than a single deal.
What are the biggest risks of investing in private AI companies?
The main risks are failure, illiquidity and valuation uncertainty. Many early-stage startups do not survive, and those that do can take seven to ten years to exit. Private shares come with limited disclosure and no continuous market price, so valuations can move sharply between funding rounds. In AI specifically, rapid progress by foundation model providers can erode a startup's advantage quickly, which makes diligence on defensibility essential.
Is it better to invest in early-stage AI startups or late-stage pre-IPO AI companies?
It depends on the investor's goals and time horizon. Late-stage pre-IPO companies like OpenAI or Databricks carry less failure risk and may list sooner, but much of their growth is already reflected in their valuations. Early-stage AI startups offer more room to grow along with greater risk, and platforms like OurCrowd that combine professional deal selection with diversified funds help investors take that risk more deliberately.




